ARTICLE | Company News
Theratechnologies, BL&H deal
October 5, 2015 7:00 AM UTC
Theratechnologies granted BL&H rights to develop and commercialize Egrifta tesamorelin in South Korea to treat HIV-associated lipodystrophy. BL&H is responsible for registration in the territory and...